Global Endovascular Treatment Devices Market Size By Type (Endovascular Aortic Repair (EVAR), Thoracic Endovascular Aortic/aneurysm Repair (TEVAR)), By Application (Hospital, Clinic), By Region, And S...

The Global Endovascular Treatment Devices Market was valued at USD 8.3 billion in 2023 and is projected to reach USD 15.6 billion by 2031, growing at a CAGR of 8.1% during the forecast period of 2023 to 2031. This growth is primarily fueled by the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and rapid advancements in medical technologies. Endovascular devices are becoming a preferred solution for treating aneurysms, stenosis, and peripheral artery diseases due to their reduced recovery time, lower procedural risks, and effectiveness in complex vascular conditions.

Drivers:

Rising Incidence of Cardiovascular Disorders:

The increasing global burden of cardiovascular diseases, especially among the aging population, is a major driver. These conditions often require endovascular interventions, boosting the demand for advanced treatment devices.

Preference for Minimally Invasive Procedures:

Patients and healthcare providers are increasingly shifting towards less invasive methods for vascular interventions. Endovascular devices reduce hospital stays and postoperative complications, making them a desirable alternative to traditional surgery.

Technological Advancements in Device Design:

Innovations in stent design, drug-eluting technologies, and imaging-guided catheters have significantly improved clinical outcomes, supporting broader adoption.

Restraints:

High Costs and Reimbursement Challenges:

The high upfront cost of endovascular devices and inconsistent reimbursement policies across regions can hinder market penetration, especially in cost-sensitive markets.

Risk of Device-Related Complications:

Despite technological progress, complications such as device migration, restenosis, or thrombosis may still occur, limiting their usage in certain high-risk patient populations.

Opportunity:

Growth in Emerging Markets:

Countries in Asia-Pacific, Latin America, and the Middle East are witnessing an upsurge in healthcare investments and infrastructure development. The increasing prevalence of vascular diseases and growing medical tourism in these regions present significant opportunities.

Expansion of Ambulatory Surgical Centers (ASCs):

The rise of outpatient care settings and ambulatory surgical centers provides an ideal environment for minimally invasive endovascular procedures, expanding the scope of device usage.

Market by System Type Insights:

By system type, Stent Systems dominated the market in 2023, particularly drug-eluting and bare-metal stents, due to their proven efficacy in treating arterial blockages. However, Atherectomy Devices are expected to register the fastest growth during the forecast period, supported by rising cases of peripheral artery disease (PAD) and increasing demand for plaque-removal technologies.

Market by End-use Insights:

The Hospitals segment accounted for the largest revenue share in 2023, owing to the availability of advanced equipment and skilled professionals. However, Ambulatory Surgical Centers are expected to see the highest growth rate due to the increasing preference for outpatient minimally invasive procedures.

Market by Regional Insights:

North America led the market in 2023, backed by a strong healthcare system, high prevalence of cardiovascular diseases, and robust adoption of advanced medical technologies. Meanwhile, the Asia-Pacific region is projected to witness the fastest CAGR, driven by growing health awareness, increased healthcare spending, and expanding access to minimally invasive treatments in countries like China and India.

Competitive Scenario:

Key players operating in the global endovascular treatment devices market include:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

Terumo Corporation

B. Braun Melsungen AG

Cardinal Health, Inc.

Cook Medical

W. L. Gore & Associates, Inc.

Endologix LLC

Penumbra Inc.

These companies are focusing on product innovation, strategic collaborations, and regulatory approvals to strengthen their global market presence. For instance:

In 2023, Medtronic launched a next-gen drug-eluting peripheral stent, improving vascular healing and reducing restenosis rates.

In 2024, Boston Scientific received FDA approval for its novel atherectomy system designed for complex lesion treatment.

In 2025, Abbott announced a strategic acquisition of a startup developing bioresorbable vascular scaffolds.

Scope of Work – Global Endovascular Treatment Devices Market

Report Metric Details

Market Size (2023) USD 8.3 billion

Projected Market Size (2031) USD 15.6 billion

CAGR (2023–2031) 8.1%

Key Segments Stent Systems, Atherectomy Devices, Balloon Catheters

Leading End-use Segment Hospitals

Leading Region North America

Key Players Medtronic, Boston Scientific, Abbott, Terumo, B. Braun, Cook Medical

Key Market Developments:

April 2023: Abbott received CE mark for its next-gen covered stent system for treating iliac artery disease.

June 2024: Cook Medical expanded its manufacturing facility in the U.S. to support growing demand for vascular products.

February 2025: Terumo introduced an AI-assisted catheter navigation system for complex peripheral interventions.

FAQs:

1) What is the current market size of the Global Endovascular Treatment Devices Market?

The market was valued at USD 8.3 billion in 2023.

2) What is the major growth driver of the Global Endovascular Treatment Devices Market?

The major growth driver is the rising global incidence of cardiovascular diseases and increasing preference for minimally invasive vascular procedures.

3) Which is the largest region during the forecast period in the Global Endovascular Treatment Devices Market?

North America is expected to remain the largest region during the forecast period.

4) Which segment accounted for the largest market share in the Global Endovascular Treatment Devices Market?

The Stent Systems segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Endovascular Treatment Devices Market?

Key players include Medtronic, Boston Scientific, Abbott Laboratories, Terumo, and B. Braun Melsungen AG.